Scarica l'app Stockscreener
1.68
0.60%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.67
Aprire:
$1.7
Volume 24 ore:
2.61M
Relative Volume:
0.73
Capitalizzazione di mercato:
$1.13B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-8.8421
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
+2.44%
1M Prestazione:
+12.00%
6M Prestazione:
+3.70%
1 anno Prestazione:
+66.34%
Intervallo 1D:
$1.67
$1.74
Intervallo di 1 settimana:
$1.6409
$1.74
Portata 52W:
$0.8601
$1.76
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.68 | 1.13B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
OPKO Health (OPK) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
OPKO Health to Announce Q4 2024 Financial Results - TipRanks
OPKO Health, Inc. to Report Q4 and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 - GlobeNewswire
OPKO Health Sets Critical Q4 Earnings Date: What The Numbers Will Reveal - StockTitan
Hidden Gems of Nasdaq: Why These Under-$5 Stocks Are Catching Eye - MotoPaddock
Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey
10 Best Nasdaq Stocks Under $5 to Buy - Insider Monkey
Y.D. More Investments Ltd Has $2.06 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health (NASDAQ:OPK) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 52% shares - Simply Wall St
Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud - Grizzly Reports
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 Shares - MarketBeat
Opko health CEO Phillip Frost buys $70,060 in stock By Investing.com - Investing.com Australia
Opko health CEO Phillip Frost buys $70,060 in stock - MSN
Clinical Laboratory Tests Market Generated Opportunities, - openPR
Clinical Laboratory Tests Market Key Players AnalysisARUP - openPR
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Billionaire Phillip Frost's health care company settles case with federal government - The Business Journals
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Insider Monkey
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
3 Stocks That Wall Street Insiders Can't Stop Buying - MSN
BioReference faces $704,349 fine for medically unnecessary blood tests - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock - MSN
OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com
Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Canada
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today
BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law
Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com South Africa
Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 29 '24 |
Buy |
1.53 |
199,072 |
305,376 |
211,911,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 22 '24 |
Buy |
1.59 |
100,000 |
159,000 |
211,712,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 14 '24 |
Buy |
1.62 |
100,000 |
161,980 |
211,612,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 08 '24 |
Buy |
1.50 |
280,183 |
421,535 |
211,512,405 |
0.06%
3.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):